Search Within

Mark Kris

  1. "Cancer Biology and Genetics Program Faculty"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (3)
Groups
  1. Cancer Biology and Genetics Program Faculty (9)
  2. Department of Medicine (9)
  3. GSK Faculty (9)
  4. Sloan Kettering Institute Faculty (9)
  5. Solid Tumor Oncology Division (9)
  6. Thoracic Oncology (9)

More Groups

People
  1. Joan Massague (6)
  2. Jamie Chaft (3)
  3. Paul Paik (3)
  4. Anna Obenauf (2)
  5. Charles Rudin (2)
  6. Derek Lee (2)

More People

Years
  1. 2022 (3)
  2. 2016 (1)
  3. 2014 (1)
  4. 2013 (1)
  5. 2009 (1)
  6. 2001 (1)

More Years

Publications
  1. Cell (2)
  2. Clinical Cancer Research (2)
  3. Cancer Discovery (1)
  4. Cancer Research (1)
  5. JTO Clinical and Research Reports (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Cell Press (2)
  3. American Society of Clinical Oncology (1)
  4. Elsevier BV (1)
  5. Nature Publishing Group (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
    Journal Article

    Paik, P. K.; Luo, J.; Ai, N.; Kim, R.; Ahn, L.; Biswas, A.; Coker, C.; Ma, W.; Wong, P.; Buonocore, D. J.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Targeting S100A9–ALDH1A1–retinoic acid signaling to suppress brain relapse in EGFR-mutant lung cancer
    Journal Article

    Biswas, A. K.; Han, S.; Tai, Y.; Ma, W.; Coker, C.; Quinn, S. A.; Shakri, A. R.; Zhong, T. J.; Scholze, H.; Lagos, G. G.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Phase 1 clinical trial of trametinib and ponatinib in patients with NSCLC harboring KRAS mutations
    Journal Article

    Arbour, K. C.; Manchado, E.; Bott, M. J.; Ahn, L.; Tobi, Y.; Ni, A. A.; Yu, H. A.; Shannon, A.; Ladanyi, M.; Perron, V.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save
  • A phase I trial of certolizumab plus chemotherapy in patients with stage IV lung adenocarcinomas
    Meeting Abstract

    Paik, P. K.; Eng, J.; Perez, L.; Ritter, E.; Ni, A.; Ng, K. K.; Fiore, J. J.; Wong, P.; Rudin, C. M.; Massague, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Serpins promote cancer cell survival and vascular co-option in brain metastasis
    Journal Article

    Valiente, M.; Obenauf, A. C.; Jin, X.; Chen, Q.; Zhang, X. H. F.; Lee, D. J.; Chaft, J. E.; Kris, M. G.; Huse, J. T.; Brogi, E.; more...
    Cell (2014)

    Fulltext@MSK | Save
  • Cooption of the reactive stroma by brain metastasis relies on protease
    Meeting Abstract

    Valiente, M.; Lee, D. J.; Obenauf, A.; Huse, J. T.; Chaft, J. E.; Kris, M. G.; Brogi, E.; Massagué, J.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis
    Journal Article

    Nguyen, D. X.; Chiang, A. C.; Zhang, X. H. F.; Kim, J. Y.; Kris, M. G.; Ladanyi, M.; Gerald, W. L.; Massague, J.
    Cell (2009)

    Fulltext@MSK | Save
  • Low-level co-expression of multiple MRP genes including the newly described MRP-7 limits intrinsic sensitivity of drug naive human tumors to a folate analogue, cisplatin and paclitaxel
    Meeting Abstract

    Wendel, H. G.; Scher, H. I.; Miller, V. A.; Kris, M. G.; Sirotnak, F. M.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo
    Journal Article

    Sirotnak, F. M.; Wendel, H. G.; Bornmann, W. G. B.; Tong, W. P.; Miller, V. A.; Scher, H. I.; Kris, M. G.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save